Investor Overview

Investor Presentation
Financial News
Jun 11, 2020

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA) (OTCQB: MDNAF), a clinical stage immuno-oncology company, today announced that Dr. Fahar Merchant, President, CEO and...

May 29, 2020

-MDNA11, a long acting IL-2 super-agonist shows potent and durable tumor control with strong memory response in tumor models- -Up to 10-fold expansion of cancer-killing immune cells in non-human...

Stock Quote
Stock Chart
Upcoming Events
No events to display
Investor Contact
For more investor information, Please contact:
Elizabeth Williams, Chief Financial Officer
Email Alerts
* Required Fields